This observation suggests that vascular endothelial cell damage caused by COVID-19 persists for a long time and that PMX-DHP treatment temporarily reduces t-PA-PAI-1 levels; however, these levels rebound after the discontinuation of PMX-DHP, as observed on Day 4. This evidence concerns the gene SERPINE1 and COVID-19.